55
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Circulating endothelial progenitor cells in postmenopausal women with and without coronary artery disease

, , , , , , , & show all
Pages 259-265 | Received 12 Aug 2008, Accepted 10 Dec 2008, Published online: 03 Jul 2009

References

  • Vitale C, Miceli M, Rosano G M. Gender-specific characteristics of atherosclerosis in menopausal women: risk factors, clinical course and strategies for prevention. Climacteric 2007; 10(Suppl 2)16–20
  • Ghani U, Shuaib A, Salam A, et al. Endothelial progenitor cells during cerebrovascular disease. Stroke 2005; 36: 151–153
  • Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964–967
  • Rauscher F M, Goldschmidt-Clermont P J, Davis B H, et al. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 2003; 108: 457–463
  • Fadini G P, de Kreutzenberg S, Albiero M, et al. Gender differences in endothelial progenitor cells and cardiovascular risk profile: the role of female estrogens. Arterioscler Thromb Vasc Biol 2008; 28: 997–1004
  • Hoetzer G L, MacEneaney O J, Irmiger H M, et al. Gender differences in circulating endothelial progenitor cell colony-forming capacity and migratory activity in middle-aged adults. Am J Cardiol 2007; 99: 46–48
  • Heiss C, Keymel S, Niesler U, Ziemann J, Kelm M, Kalka C. Impaired progenitor cell activity in age-related endothelial dysfunction. J Am Coll Cardiol 2005; 45: 1441–1448
  • Fadini G P, de Kreutzenberg S V, Coracina A, et al. Circulating CD34+ cells, metabolic syndrome, and cardiovascular risk. Eur Heart J 2006; 27: 2247–2255
  • Wang Y, Johnsen H E, Mortensen S, et al. Changes in circulating mesenchymal stem cells, stem cell homing factor, and vascular growth factors in patients with acute ST elevation myocardial infarction treated with primary percutaneous coronary intervention. Heart 2006; 92: 768–774
  • Rehman J, Li J, Orschell C M, March K L. Peripheral blood “endothelial progenitor cells” are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 2003; 107: 1164–1169
  • Guven H, Shepherd R M, Bach R G, Link D C. The number of endothelial progenitor cell colonies in the blood is increased in patients with angiographically significant coronary artery disease. J Am Coll Cardiol 2006; 48: 1579–1587
  • Waters D, Lesperance J, Craven T E, Hudon G, Gillam L D. Advantages and limitations of serial coronary arteriography for the assessment of progression and regression of coronary atherosclerosis: implications for clinical trials. Circulation 1993; 87(Suppl II)38–47
  • Reiber J H, Serruys P W, Kooijman C J, et al. Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms. Circulation 1985; 71: 280–288
  • Murphy C, Kanaganayagam G S, Jiang B, et al. Vascular dysfunction and reduced circulating endothelial progenitor cells in young healthy UK South Asian men. Arterioscler Thromb Vasc Biol 2007; 27: 936–942
  • Peichev M, Naiyer A J, Pereira D, et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000; 95: 952–958
  • Silvestre J S, Gojova A, Brun V, et al. Transplantation of bone marrow-derived mononuclear cells in ischemic apolipoprotein E-knockout mice accelerates atherosclerosis without altering plaque composition. Circulation 2003; 108: 2839–2842
  • George J, Afek A, Abashidze A, et al. Transfer of endothelial progenitor and bone marrow cells influences atherosclerotic plaque size and composition in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 2005; 25: 2636–2641
  • Vasa M, Fichtlscher S, Aicher A, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001; 89: E1–E7
  • Hill J, Zalos G, Halcox J, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348: 593–600
  • Schmidt-Lucke C, Rossig L, Fichtlscheer S, et al. Reduced number of circulating endothelial progenitor cells predict future cardiovascular events. Proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005; 111: 2981–2987
  • Rosano G M, Vitale C, Marazzi G, Volterrani M. Menopause and cardiovascular disease: the evidence. Climacteric 2007; 10(Suppl 1)19–24
  • Quyyumi A A, Hill J M. Circulating endothelial progenitor cells as novel biological determinants of vascular function and risk. Can J Cardiol 2004; 20(Suppl B)44–8B
  • Stauffer B L, Hoetzer G L, Van Guilder G P, Smith D T, Desouza C A. Gender differences in endothelial tissue-type plasminogen activator release in middle-aged adults. J Am Coll Cardiol 2005; 45: 1547–1549
  • Min T Q, Zhu C J, Xiang W X, Hui Z J, Peng S Y. Improvement in endothelial progenitor cells from peripheral blood by ramipril therapy in patients with stable coronary artery disease. Cardiovasc Drugs Ther 2004; 18: 203–209

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.